Neurocrine Biosciences Inc (NBIX)
125.03
+1.74
(+1.41%)
USD |
NASDAQ |
Nov 21, 16:00
123.15
-1.88
(-1.50%)
After-Hours: 20:00
Neurocrine Biosciences Market Cap: 12.66B for Nov. 21, 2024
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| November 20, 2024 | 12.48B |
| November 19, 2024 | 12.06B |
| November 18, 2024 | 11.91B |
| November 15, 2024 | 11.89B |
| November 14, 2024 | 12.44B |
| November 13, 2024 | 12.71B |
| November 12, 2024 | 12.86B |
| November 11, 2024 | 12.88B |
| November 08, 2024 | 12.73B |
| November 07, 2024 | 12.55B |
| November 06, 2024 | 12.69B |
| November 05, 2024 | 12.30B |
| November 04, 2024 | 12.20B |
| November 01, 2024 | 12.37B |
| October 31, 2024 | 12.18B |
| October 30, 2024 | 12.59B |
| October 29, 2024 | 11.76B |
| October 28, 2024 | 11.76B |
| October 25, 2024 | 11.75B |
| October 24, 2024 | 11.70B |
| October 23, 2024 | 11.65B |
| October 22, 2024 | 11.82B |
| October 21, 2024 | 11.80B |
| October 18, 2024 | 11.94B |
| October 17, 2024 | 11.99B |
| Date | Value |
|---|---|
| October 16, 2024 | 11.98B |
| October 15, 2024 | 11.87B |
| October 14, 2024 | 11.78B |
| October 11, 2024 | 11.69B |
| October 10, 2024 | 11.38B |
| October 09, 2024 | 11.30B |
| October 08, 2024 | 11.30B |
| October 07, 2024 | 11.35B |
| October 04, 2024 | 11.54B |
| October 03, 2024 | 11.32B |
| October 02, 2024 | 11.53B |
| October 01, 2024 | 11.55B |
| September 30, 2024 | 11.66B |
| September 27, 2024 | 11.62B |
| September 26, 2024 | 11.71B |
| September 25, 2024 | 11.57B |
| September 24, 2024 | 11.76B |
| September 23, 2024 | 11.89B |
| September 20, 2024 | 11.95B |
| September 19, 2024 | 12.16B |
| September 18, 2024 | 12.10B |
| September 17, 2024 | 12.35B |
| September 16, 2024 | 12.34B |
| September 13, 2024 | 12.34B |
| September 12, 2024 | 12.25B |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
6.876B
Minimum
Jan 27 2022
15.46B
Maximum
Aug 01 2024
10.36B
Average
9.941B
Median
Market Cap Benchmarks
| Repligen Corp | 7.939B |
| West Pharmaceutical Services Inc | 23.24B |
| Bruker Corp | 8.525B |
| The Cooper Companies Inc | 19.90B |
| Integra Lifesciences Holdings Corp | 1.774B |
Market Cap Related Metrics
| PE Ratio | 33.52 |
| PS Ratio | 5.770 |
| PEG Ratio | 0.3334 |
| Price to Book Value | 4.656 |
| Price to Free Cash Flow | 29.40 |
| Price | 125.03 |
| Earnings Yield | 2.98% |
| PEGY Ratio | 0.3334 |
| Operating PE Ratio | 22.00 |
| Normalized PE Ratio | 39.52 |